跳至主要内容
临床试验/jRCT2071240021
jRCT2071240021进行中(未招募)不适用

Clinical pharmacology study to evaluate the effects of food on TAS-115 in healthy subjects

Taiho Pharmaceutical Co., Ltd.0 个研究点目标入组 32 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
32
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Crossover Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 40age old not(—)
性别
Male

入选标准

  • (1) Provided written informed consent
  • (2) Men aged 18 or older and younger than 40 years at the time of consent
  • (3) Weigh at least 50.0 kg at the time of screening tests with a body mass index (BMI, weight [kg]/[height {m}]2) ranging from 18.5 to < 25.0 kg/m2
  • (4) Vital signs obtained in screening tests within the following ranges
  • a) Systolic blood pressure (in supine position), 90 to 139 mmHg
  • b) Diastolic blood pressure (in supine position), 40 to 89 mmHg
  • c) Pulse rate ranging from 40 to 99 beats/min
  • d) Body temperature (axilla) ranging from 35.0 to 37.4
  • (5) Judged to be healthy by the investigator based on the examination findings (subjective symptoms and objective findings), blood pressure, pulse rate, body temperature, 12-lead ECG, and laboratory tests (hematology test, biochemistry test, coagulation test, and urinalysis) at the time of screening tests

排除标准

  • (1) Accompanying diseases considered inappropriate for participation in this study including hepatic diseases, renal diseases, gastrointestinal diseases, cardiovascular diseases, hematologic diseases, respiratory diseases, immunologic or allergic diseases, neurological or psychiatric diseases, metabolic or endocrinological diseases, or malignant tumors, or a history of these diseases
  • (2) Had current or previous drug abuse (including use of illicit drugs) or alcoholism
  • (3) History of hypersensitivity to any component of TAS-115
  • (4) Consumed foods or beverages containing pomegranate, pomelo, or star fruit within 7 days before study drug administration. Excessive consumption of foods or beverages containing cruciferous vegetables (e.g., kale, broccoli, watercress, collard greens, kohlrabi, Brussels sprouts, and mustard) within 7 days before study drug administration
  • (5) Consumed foods or beverages containing grapefruit or bitter orange within 14 days before study drug administration
  • (6) Consumed foods or beverages containing the St. John's Wort within 28 days before study drug administration
  • (7) Consumed foods or beverages containing fruit juices, alcohol, caffeine, and xanthine within 3days before study drug administration

结局指标

主要结局

-

PK parameters of TAS-115 (Cmax, AUClast, and AUCinf)

次要结局

未报告次要终点

研究者

相似试验